openPR Logo
Press release

Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare

06-10-2025 09:42 PM CET | Health & Medicine

Press release from: ABNewswire

Ibogaine by David Dardashti Announces Landmark Initiative with

MIAMI, FL - June 10, 2025 - Ibogaine by David Dardashti, a leader in innovative wellness and treatment solutions, today announced a forward-thinking initiative following pivotal discussions with members of the Google Chrome team at their Miami, Florida office. The clinic will integrate Chrome's advanced cloud and security technologies to fundamentally enhance its operational framework and patient care protocols, setting a new standard for security and long-term patient success in the treatment industry.

The decision follows a collaborative meeting between Gavriel Dardashti and the Google Chrome team, where they explored the future of secure, cloud-first operating systems in a clinical environment. Recognizing the critical need for robust data protection and efficient digital infrastructure, the clinic has committed to a comprehensive implementation of ChromeOS and associated Google technologies. This transition will create a secure, unified ecosystem that safeguards sensitive patient information with Google's world-class security architecture while streamlining both administrative and clinical processes through highly efficient cloud computing.

The technological integration extends directly into the clinic's pioneering treatment methodologies. During a patient's stay, the new systems will ensure all digital interactions and data entry points are secure and seamless. More importantly, the initiative introduces a revolutionary approach to post-treatment support, a critical phase in a patient's journey.

"This isn't just about upgrading our IT systems; it's about upgrading our standard of care," said Gavriel Dardashti, son of the founder of the clinic. "By harnessing the power and security of Google's cloud ecosystem, we can provide our patients with a safer, more connected, and more supportive recovery journey. Our goal is to use this technology to stay engaged with our patients long after they leave our facility, giving them the tools and the confidence to achieve lasting success. This collaboration allows us to build a more resilient and effective model for aftercare."

By leveraging ChromeOS, the clinic will provide patients with tools and platforms to monitor their progress and maintain a connection to their support network. The utilization of Google's cloud technologies will enable secure data monitoring and communication, offering insights into patient success and allowing for timely intervention and encouragement. This data-driven approach aims to ensure greater long-term success rates and provide a continuum of care that extends far beyond the clinic's walls.

About Ibogaine by David Dardashti:

Ibogaine by David Dardashti is a premier treatment center dedicated to providing innovative and effective paths to recovery. The clinic is committed to a holistic approach that integrates cutting-edge science with compassionate, individualized care. Its mission is to empower individuals to overcome their challenges and build a foundation for a healthy, successful, and sustainable future.

Media Contact
Company Name: Ibogaine By David Dardashti
Contact Person: Cole Barressi
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=ibogaine-by-david-dardashti-announces-landmark-initiative-with-google-chrome-team-to-enhance-patient-security-and-aftercare]
Country: United States
Website: http://www.ibogaineclinic.com

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Ibogaine by David Dardashti Announces Landmark Initiative with Google Chrome Team to Enhance Patient Security and Aftercare here

News-ID: 4060365 • Views:

More Releases from ABNewswire

Chronic Wounds Market Dynamics Indicate Upward Trajectory Through 2034, Reports DelveInsight | Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE
Chronic Wounds Market Dynamics Indicate Upward Trajectory Through 2034, Reports …
The Key Chronic Wounds Companies in the market include - Paracrine, Inc, Oneness Biotech, MediWound, PolarityTE, and others. The Chronic Wounds market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Chronic Wounds pipeline products will significantly revolutionize the Chronic Wounds market dynamics. DelveInsight's "Chronic Wounds Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Chronic Wounds,
High-grade Glioma Market to Experience Notable Growth in Forecast Span by 2034, DelveInsight Predicts | Rigel Pharmac, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharma
High-grade Glioma Market to Experience Notable Growth in Forecast Span by 2034, …
The Key High-grade Glioma Companies in the market include - Everfront Biotech Co., Ltd., BioMimetix JV, LLC, Chimerix, Laminar Pharmaceuticals, Nationwide Children's Hospital, Rigel Pharmaceuticals, Orbus Therapeutics, BioMimetix, Bayer, MedImmune, DNAtrix, Chimerix, CNS Pharmaceuticals, VBI Vaccines, Kazia Therapeutics, Aivita Biomedical, Medicenna Therapeutics, DelMar Pharmaceuticals, Bristol-Myers Squibb, Laminar Pharmaceuticals, Immunomic Therapeutics, Inovio Pharmaceuticals, and others. DelveInsight's "High-grade Glioma Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the High-grade
Cutaneous Lupus Erythematosus Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen, Gilead
Cutaneous Lupus Erythematosus Market Insights Highlight Expanding Outlook Till 2 …
The Key Cutaneous Lupus Erythematosus Companies in the market include - Biogen, Horizon Therapeutics, Bristol-Myers Squibb, AstraZeneca, Sanofi, Amgen, Biogen, Gilead Sciences, Pfizer, Bristol-Myers Squibb, Novartis, Rigel Pharmaceuticals, Merck, and others. DelveInsight's "Cutaneous Lupus Erythematosus Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Cutaneous Lupus Erythematosus, historical and forecasted epidemiology as well as the Cutaneous Lupus Erythematosus market trends in the United States, EU4 (Germany, Spain,
Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a Defining Moment in Her Artistic Journey
Starry Venus Submits Album SOUL for Grammy Registered Consideration, Marking a D …
Sedona, AZ - Visionary artist Starry Venus has officially submitted her album SOUL for Grammy Registered consideration, a milestone that underscores her growing influence as a boundary-pushing voice in today's music scene. Known for her ethereal soundscapes and empowering lyrical narratives, Starry Venus captivates audiences with music that blends artistry, spirituality, and authenticity. The submitted album, SOUL, showcases Starry Venus's ability to fuse raw emotion with expansive sound design across multiple

All 5 Releases


More Releases for Dardashti

Gavriel Dardashti, Son of Ibogaine by David Dardashti CEO, to Showcase Google Cl …
Leveraging Google Cloud, the Proposed Technology Aims to Provide Accessible Mental Wellness Insights and Track Long-Term Patient Progress, Potentially Correlating with Ibogaine Treatment Outcomes HOLLYWOOD, FL - April 8, 2025 - Gavriel Dardashti, an innovator in the wellness technology space and son of David Dardashti, CEO of Ibogaine by David Dardashti, has announced his attendance at the upcoming Google Next '25 conference. During the event, Mr. Dardashti plans to engage with
Ibogaine By David Dardashti Offers a Solution to Parkinsons
Ibogaine By David Dardashti today announced that preliminary research suggests ibogaine, a naturally occurring psychoactive alkaloid found in the root bark of the Tabernanthe iboga plant, may hold potential for treating Parkinson's disease. While some studies indicate ibogaine could impact the neurotransmitter systems involved in Parkinson's, the organization emphasizes the need for significantly more research to fully understand its effects and potential risks. Parkinson's disease is a chronic and progressive neurodegenerative
Ibogaine by David Dardashti Explores Electrodynamics Based Quantum Computing
Gavriel Dardashti, son of renowned expert in ibogaine treatment and founder of Ibogaine by David Dardashti, is attending the Adaptive Quantum Circuits events to explore the potential of quantum technology in revolutionizing mental health care. Dardashti is specifically interested in leveraging quantum computing's power to develop a user-friendly mobile app that supports individuals in managing their mental well-being during the critical months following ibogaine treatment. Ibogaine, a naturally occurring psychoactive substance,
Gavriel Dardashti Unveils Electrodynamics Hyperspace Circuit for Quantum Computi …
Gavriel Dardashti, a visionary in the field of theoretical physics, has achieved a significant breakthrough with the development of the first functional prototype circuit utilizing electrodynamics in eleven-dimensional hyperspace. This revolutionary circuit, while currently in its basic stage, demonstrates the feasibility of harnessing hyperspace principles for practical applications, particularly in the realm of quantum computing. Dardashti's innovation addresses a critical challenge in quantum computing: overheating. By implementing a more natural and
Ibogaine By David Dardashti Revolutionizes Treatment with Groundbreaking Softwar …
Ibogaine By David Dardashti is proud to announce the launch of its revolutionary software platform designed to optimize ibogaine treatment for addiction, trauma, and depression. This cutting-edge software leverages advanced mathematical modeling and statistical analysis to personalize ibogaine dosing for maximum efficiency and safety. Unparalleled Precision in Ibogaine Dosing Ibogaine By David Dardashti's software utilizes triple integrals to model bioavailability factors, ensuring that the optimal amount of ibogaine is delivered to the
Instruction on Quadratic Formula to High School Students by Gavriel Dardashti
Teaching the quadratic formula to high school students is an effective method that can highlight a teacher's skill in simplifying intricate ideas into comprehensible segments. By illustrating the sequential procedure of resolving quadratic equations using the formula, teachers can assist students in understanding the fundamental principles of algebra and problem-solving. This not only improves students' comprehension of mathematics but also cultivates critical thinking abilities and self-assurance in handling difficult problems. Moreover,